» Articles » PMID: 17311085

Immune Recovery in Children Undergoing Allogeneic Stem Cell Transplantation: Absolute CD8+ CD3+ Count Reconstitution is Associated with Survival

Overview
Specialty General Surgery
Date 2007 Feb 22
PMID 17311085
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the correlation between kinetics of immune reconstitution and survival, we prospectively evaluated lymphocyte subsets in 32 paediatric patients undergoing allogeneic stem cell transplantation (SCT) for haematological malignancies. Four-colour flow cytometric analysis was performed at short intervals with a median follow-up of 4 years post SCT. A total of 50% of patients reached age-matched 5th percentile of natural killer, cytotoxic T, B and helper T cells 4, 9, 20 and 28 weeks after SCT, respectively, which increased to more than 80% within 1 year after SCT. Transplantation of peripheral blood stem cells (PBSC) seemed to elicit the fastest reconstitution of CD3+, CD4+ CD3+, CD8+ CD3+ and naïve T cells compared to bone marrow (BM) or CD34-selected PBSC, which did not differ. Most importantly, we observed a significantly higher number of survivors among patients whose CD8+ CD3+ absolute counts rose above the 5th percentile of age-matched normal levels during the first year post SCT compared to patients who never reached these levels (19/25 vs 0/7, P<0.001). This was still present in both subgroups, BM- and CD34-selected grafts (P=0.03, 0.02). These results from a small patient sample underline the importance of particular lymphocyte subsets for the outcome of children undergoing SCT. A larger study with detailed subset analysis is underway.

Citing Articles

Immune Reconstitution in Pediatric Aplastic Anemia after Allogeneic Hematopoietic Stem-cell Transplantation.

Wang J, Yuan M, Zhu G, Wu R, Jia C, Wang B Int J Med Sci. 2022; 19(5):821-828.

PMID: 35693743 PMC: 9149648. DOI: 10.7150/ijms.70146.


Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias.

Spadea M, Saglio F, Tripodi S, Menconi M, Zecca M, Fagioli F Transplant Direct. 2021; 7(11):e774.

PMID: 34646937 PMC: 8500617. DOI: 10.1097/TXD.0000000000001226.


Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation.

de Koning C, Tao W, Lacna A, van Veghel K, Horwitz M, Sanz G Bone Marrow Transplant. 2021; 56(11):2826-2833.

PMID: 34312498 PMC: 8563413. DOI: 10.1038/s41409-021-01417-4.


Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation.

Dekker L, de Koning C, Lindemans C, Nierkens S Cancers (Basel). 2020; 12(7).

PMID: 32698396 PMC: 7409323. DOI: 10.3390/cancers12071974.


Toward Functional Immune Monitoring in Allogeneic Stem Cell Transplant Recipients.

Naik S, Vasileiou S, Aguayo-Hiraldo P, Mukhi S, Sasa G, Martinez C Biol Blood Marrow Transplant. 2020; 26(5):911-919.

PMID: 31927102 DOI: 10.1016/j.bbmt.2020.01.005.